Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Merck & Co
(NY:
MRK
)
125.26
-0.59 (-0.47%)
Official Closing Price
Updated: 7:00 PM EDT, Jul 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
6,467,082
Open
127.24
Bid (Size)
123.80 (1)
Ask (Size)
125.50 (5)
Prev. Close
125.85
Today's Range
125.05 - 128.73
52wk Range
99.14 - 134.63
Shares Outstanding
2,531,374,696
Dividend Yield
2.33%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Merck & Co's Options: A Look at What the Big Money is Thinking
Today 14:16 EDT
Via
Benzinga
Merck Receives Positive EU CHMP Opinion for KEYTRUDA® (pembrolizumab) Plus Padcev® (enfortumab vedotin-ejfv) as First-Line Treatment for Patients With Unresectable or Metastatic Urothelial Carcinoma
Today 6:50 EDT
From
Merck & Co., Inc.
Via
Business Wire
Performance
YTD
+10.61%
+10.61%
1 Month
-5.76%
-5.76%
3 Month
-4.18%
-4.18%
6 Month
+4.27%
+4.27%
1 Year
+16.91%
+16.91%
More News
Read More
Smart Money Is Betting Big In MRK Options
July 25, 2024
Via
Benzinga
Earnings Divide Dow Industrials As Crux Of Q2 Season Approaches
July 25, 2024
Via
Investor's Business Daily
Topics
Stocks
Exposures
US Equities
Merck Competes With Sanofi/AstraZeneca As Its RSV Treatment Drug Meets Primary Goal In Late-Stage Study In Infants
July 23, 2024
Via
Benzinga
Merck & Co Inc. DCF Valuation: Is The Stock Undervalued?
July 19, 2024
Via
Talk Markets
Merck & Co's Options Frenzy: What You Need to Know
July 18, 2024
Via
Benzinga
Merck Announces Fourth-Quarter 2024 Dividend
July 23, 2024
From
Merck & Co., Inc.
Via
Business Wire
Billionaires Are Loading Up on This Surging Dow Stock. Should You?
July 23, 2024
Via
The Motley Fool
Topics
Stocks
Exposures
US Equities
Merck Announces Topline Results from Phase 2b/3 Trial of Clesrovimab (MK-1654), an Investigational Respiratory Syncytial Virus Preventative Monoclonal Antibody for Infants
July 23, 2024
From
Merck & Co., Inc.
Via
Business Wire
Billionaires Are Buying These 2 Beaten-Down Stocks. Are They Smart Buys for Your Portfolio?
July 21, 2024
Via
The Motley Fool
Evaluating Merck & Co Against Peers In Pharmaceuticals Industry
July 17, 2024
Via
Benzinga
NYSE:MRK is probably undervalued for the fundamentals it is displaying.
July 17, 2024
Via
Chartmill
Merck's Acquisition of EyeBio Finalized
July 12, 2024
Via
Benzinga
This Hidden Gem Vanguard ETF Is Chock-Full of Magnificent Stocks. Here's Why It's a Buy Now.
July 21, 2024
Via
The Motley Fool
Topics
ETFs
Stock Market Rotation Gets Rough; ASML, Eli Lilly, CrowdStrike, UnitedHealth In Focus: Weekly Review
July 19, 2024
Via
Investor's Business Daily
Merck Gets Legal Victory As Appeals Court Dismisses Shingles Vaccine Some 1,200 Lawsuits
July 18, 2024
Via
Benzinga
Topics
Lawsuit
Exposures
Financial
Legal
2 Magnificent Stocks to Buy With $500
July 18, 2024
Via
The Motley Fool
3 Top Cancer Treatment Stocks to Buy Now
July 17, 2024
Via
InvestorPlace
3 Biotech Stocks to Buy in Case of Another Pandemic
July 16, 2024
Via
InvestorPlace
Merck to Share New Research and Host Community-Focused Symposia at AIDS 2024
July 16, 2024
From
Merck & Co., Inc.
Via
Business Wire
Forget Nvidia: Billionaires Are Dumping It and Piling Into These 3 Surprising Value Stocks Instead
July 16, 2024
Via
The Motley Fool
Bernie Sanders: 'Getting Sick In America Should Not Mean Going Bankrupt, Losing Your Home, Car, Or Life Savings'
July 15, 2024
Via
Benzinga
Topics
Bankruptcy
Exposures
Financial
Legal
Positive News is Driving This Cancer Drug Maker’s Stock Higher
July 15, 2024
Via
MarketBeat
Australia Based Cancer Focused Immutep's Lead Cancer Drug Shows 'Meaningful Response' In Untreated Head & Neck Cancer, Stock Soars
July 12, 2024
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.